Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glucagon: hormone or therapeutic agent?

K Hall-Boyer, G P Zaloga, B Chernow

    Critical Care Medicine
    |July 1, 1984
    PubMed
    Summary

    Glucagon, a vital hormone, offers diverse therapeutic applications in critical care. This review highlights its effectiveness in treating conditions from hypoglycemia to specific drug overdoses and shock.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Early enteral nutrition in acutely ill patients: a systematic review.

    Critical care medicine·2002
    Same author

    Sepsis-induced adrenal deficiency syndrome.

    Critical care medicine·2001
    Same author

    CPR in terminally ill patients?

    Resuscitation·2001
    Same author

    The safety and efficacy of propofol containing EDTA: a randomised clinical trial programme focusing on cation and trace metal homeostasis in critically ill patients.

    Intensive care medicine·2001
    Same author

    Propofol-containing sedatives increase levels of parathyroid hormone.

    Intensive care medicine·2001
    Same author

    Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients.

    Intensive care medicine·2001

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Critical Care Medicine

    Background:

    • Glucagon's endogenous hormonal functions are well-established.
    • Its clinical applications in critical care settings are underexplored.
    • This review aims to consolidate current knowledge on glucagon's therapeutic uses.

    Purpose of the Study:

    • To review the established and potential clinical uses of glucagon in critical care medicine.
    • To provide a comprehensive overview of glucagon's efficacy in various medical emergencies.
    • To emphasize the therapeutic potential of glucagon beyond its known hormonal roles.

    Main Methods:

    • Literature review of studies and case reports on glucagon's clinical applications.
    • Synthesis of data on glucagon's effectiveness in diverse critical care scenarios.
    • Analysis of glucagon's pharmacological actions relevant to its therapeutic uses.

    Main Results:

    • Glucagon is a proven treatment for hypoglycemia, cardiogenic shock, heart failure, and propranolol overdose.
    • Effective in managing esophageal meat impaction, ureteral colic, and acute diverticulitis.
    • Shows potential utility in treating endotoxin/hypovolemic shock and toxicity from procainamide, quinidine, or ouabain.

    Conclusions:

    • Glucagon is a versatile therapeutic agent with broad applications in critical care.
    • Its use extends beyond glycemic control to managing various emergencies and toxicities.
    • Further research may expand glucagon's role in critical care medicine.

    Related Experiment Videos